nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—Hyperammonaemia—Topiramate—obesity	0.0156	0.0664	CcSEcCtD
Glycine—Blindness transient—Topiramate—obesity	0.00803	0.0343	CcSEcCtD
Glycine—Pulmonary congestion—Bupropion—obesity	0.00762	0.0325	CcSEcCtD
Glycine—GLYATL1—respiratory system—obesity	0.00744	0.0272	CbGeAlD
Glycine—GLRA2—hindbrain—obesity	0.0064	0.0234	CbGeAlD
Glycine—Respiratory tract congestion—Bupropion—obesity	0.00631	0.0269	CcSEcCtD
Glycine—BAAT—endocrine gland—obesity	0.00607	0.0222	CbGeAlD
Glycine—Aminocaproic Acid—PLG—obesity	0.00587	0.479	CrCbGaD
Glycine—GCAT—hindbrain—obesity	0.00565	0.0206	CbGeAlD
Glycine—BAAT—liver—obesity	0.00547	0.02	CbGeAlD
Glycine—ALAS2—respiratory system—obesity	0.0053	0.0194	CbGeAlD
Glycine—L-Alanine—GPT—obesity	0.00476	0.389	CrCbGaD
Glycine—GLYAT—adipose tissue—obesity	0.00473	0.0173	CbGeAlD
Glycine—GARS—hindbrain—obesity	0.00451	0.0165	CbGeAlD
Glycine—GRIN2C—hindbrain—obesity	0.00444	0.0162	CbGeAlD
Glycine—Urinary retention—Phenylpropanolamine—obesity	0.0043	0.0184	CcSEcCtD
Glycine—Polyuria—Diethylpropion—obesity	0.00429	0.0183	CcSEcCtD
Glycine—GATM—hindbrain—obesity	0.00428	0.0156	CbGeAlD
Glycine—GNMT—islet of Langerhans—obesity	0.00426	0.0156	CbGeAlD
Glycine—SLC32A1—pituitary gland—obesity	0.00396	0.0145	CbGeAlD
Glycine—GLYATL1—endocrine gland—obesity	0.00391	0.0143	CbGeAlD
Glycine—PIPOX—islet of Langerhans—obesity	0.00377	0.0138	CbGeAlD
Glycine—Lung disorder—Sibutramine—obesity	0.00373	0.0159	CcSEcCtD
Glycine—GLYAT—endocrine gland—obesity	0.00368	0.0134	CbGeAlD
Glycine—Angina pectoris—Phentermine—obesity	0.00365	0.0156	CcSEcCtD
Glycine—ALAS2—adipose tissue—obesity	0.00358	0.0131	CbGeAlD
Glycine—GLYATL1—liver—obesity	0.00352	0.0129	CbGeAlD
Glycine—GCAT—respiratory system—obesity	0.00345	0.0126	CbGeAlD
Glycine—SLC6A9—adrenal gland—obesity	0.00342	0.0125	CbGeAlD
Glycine—Urinary retention—Cimetidine—obesity	0.00341	0.0146	CcSEcCtD
Glycine—GLYAT—liver—obesity	0.00331	0.0121	CbGeAlD
Glycine—GPR18—adipose tissue—obesity	0.00331	0.0121	CbGeAlD
Glycine—ALAS1—islet of Langerhans—obesity	0.0032	0.0117	CbGeAlD
Glycine—GCSH—adipose tissue—obesity	0.00311	0.0113	CbGeAlD
Glycine—Cardiovascular disorder—Orlistat—obesity	0.0031	0.0132	CcSEcCtD
Glycine—GRIN2A—hindbrain—obesity	0.00307	0.0112	CbGeAlD
Glycine—SLC36A1—hindbrain—obesity	0.00305	0.0111	CbGeAlD
Glycine—ALAS1—respiratory system—obesity	0.00302	0.0111	CbGeAlD
Glycine—Vision blurred—Phendimetrazine—obesity	0.00301	0.0128	CcSEcCtD
Glycine—Cardiovascular disorder—Sibutramine—obesity	0.003	0.0128	CcSEcCtD
Glycine—GPR18—adrenal gland—obesity	0.00297	0.0109	CbGeAlD
Glycine—GARS—islet of Langerhans—obesity	0.00292	0.0107	CbGeAlD
Glycine—GCAT—adrenal cortex—obesity	0.0029	0.0106	CbGeAlD
Glycine—Tachycardia—Methamphetamine—obesity	0.00289	0.0123	CcSEcCtD
Glycine—Tachycardia—Benzphetamine—obesity	0.00279	0.0119	CcSEcCtD
Glycine—ALAS2—endocrine gland—obesity	0.00279	0.0102	CbGeAlD
Glycine—GCSH—adrenal gland—obesity	0.00279	0.0102	CbGeAlD
Glycine—GATM—islet of Langerhans—obesity	0.00277	0.0101	CbGeAlD
Glycine—GARS—respiratory system—obesity	0.00275	0.0101	CbGeAlD
Glycine—GNMT—pituitary gland—obesity	0.00273	0.00996	CbGeAlD
Glycine—Acidosis—Topiramate—obesity	0.00265	0.0113	CcSEcCtD
Glycine—Cardiovascular disorder—Bupropion—obesity	0.00262	0.0112	CcSEcCtD
Glycine—GLDC—pituitary gland—obesity	0.00258	0.00944	CbGeAlD
Glycine—GPR18—endocrine gland—obesity	0.00258	0.00942	CbGeAlD
Glycine—Vision blurred—Phenylpropanolamine—obesity	0.00257	0.011	CcSEcCtD
Glycine—Salivary hypersecretion—Sibutramine—obesity	0.00256	0.0109	CcSEcCtD
Glycine—Tachycardia—Phendimetrazine—obesity	0.00254	0.0108	CcSEcCtD
Glycine—ALAS1—adrenal cortex—obesity	0.00254	0.00927	CbGeAlD
Glycine—AGXT—endocrine gland—obesity	0.00252	0.00921	CbGeAlD
Glycine—ALAS2—liver—obesity	0.00251	0.00918	CbGeAlD
Glycine—GNMT—adrenal gland—obesity	0.00243	0.0089	CbGeAlD
Glycine—GCSH—endocrine gland—obesity	0.00242	0.00883	CbGeAlD
Glycine—PIPOX—pituitary gland—obesity	0.00241	0.00881	CbGeAlD
Glycine—PIPOX—adipose tissue—obesity	0.0024	0.00878	CbGeAlD
Glycine—SHMT2—respiratory system—obesity	0.0024	0.00876	CbGeAlD
Glycine—Urticaria—Methamphetamine—obesity	0.00235	0.01	CcSEcCtD
Glycine—GCAT—pituitary gland—obesity	0.00234	0.00855	CbGeAlD
Glycine—GCAT—adipose tissue—obesity	0.00233	0.00852	CbGeAlD
Glycine—ALAS1—cardiovascular system—obesity	0.00232	0.00846	CbGeAlD
Glycine—GARS—adrenal cortex—obesity	0.00231	0.00845	CbGeAlD
Glycine—GLDC—adrenal gland—obesity	0.00231	0.00843	CbGeAlD
Glycine—Encephalopathy—Topiramate—obesity	0.00228	0.00975	CcSEcCtD
Glycine—GRIN2C—adrenal cortex—obesity	0.00227	0.00831	CbGeAlD
Glycine—AGXT—liver—obesity	0.00227	0.0083	CbGeAlD
Glycine—Urticaria—Benzphetamine—obesity	0.00227	0.00969	CcSEcCtD
Glycine—Polyuria—Orlistat—obesity	0.00225	0.00962	CcSEcCtD
Glycine—Salivary hypersecretion—Bupropion—obesity	0.00223	0.00954	CcSEcCtD
Glycine—Hypersensitivity—Methamphetamine—obesity	0.00218	0.00932	CcSEcCtD
Glycine—GCSH—liver—obesity	0.00218	0.00796	CbGeAlD
Glycine—Tachycardia—Phenylpropanolamine—obesity	0.00217	0.00927	CcSEcCtD
Glycine—PIPOX—adrenal gland—obesity	0.00215	0.00787	CbGeAlD
Glycine—AGXT2—endocrine gland—obesity	0.00214	0.00783	CbGeAlD
Glycine—Vision blurred—Diethylpropion—obesity	0.00214	0.00913	CcSEcCtD
Glycine—Oedema—Phentermine—obesity	0.00213	0.00909	CcSEcCtD
Glycine—GNMT—endocrine gland—obesity	0.00211	0.00772	CbGeAlD
Glycine—GARS—cardiovascular system—obesity	0.00211	0.00771	CbGeAlD
Glycine—Hypersensitivity—Benzphetamine—obesity	0.00211	0.00899	CcSEcCtD
Glycine—Coma—Bupropion—obesity	0.0021	0.00897	CcSEcCtD
Glycine—GCAT—adrenal gland—obesity	0.00209	0.00764	CbGeAlD
Glycine—Thirst—Orlistat—obesity	0.00208	0.00888	CcSEcCtD
Glycine—Hypotension—Phenylpropanolamine—obesity	0.00208	0.00887	CcSEcCtD
Glycine—Tachycardia—Phentermine—obesity	0.00208	0.00887	CcSEcCtD
Glycine—ALAS1—pituitary gland—obesity	0.00205	0.00749	CbGeAlD
Glycine—ALAS1—adipose tissue—obesity	0.00204	0.00746	CbGeAlD
Glycine—Diarrhoea—Methamphetamine—obesity	0.00203	0.00865	CcSEcCtD
Glycine—Thirst—Sibutramine—obesity	0.00201	0.00859	CcSEcCtD
Glycine—GLDC—endocrine gland—obesity	0.002	0.00731	CbGeAlD
Glycine—Convulsion—Diethylpropion—obesity	0.00197	0.00839	CcSEcCtD
Glycine—Dizziness—Methamphetamine—obesity	0.00196	0.00836	CcSEcCtD
Glycine—Diarrhoea—Benzphetamine—obesity	0.00196	0.00834	CcSEcCtD
Glycine—AGXT2—liver—obesity	0.00193	0.00706	CbGeAlD
Glycine—ALAS1—digestive system—obesity	0.00192	0.00703	CbGeAlD
Glycine—GNMT—liver—obesity	0.0019	0.00696	CbGeAlD
Glycine—Polyuria—Bupropion—obesity	0.0019	0.00812	CcSEcCtD
Glycine—Dizziness—Benzphetamine—obesity	0.00189	0.00806	CcSEcCtD
Glycine—PIPOX—endocrine gland—obesity	0.00187	0.00683	CbGeAlD
Glycine—GARS—pituitary gland—obesity	0.00187	0.00683	CbGeAlD
Glycine—GARS—adipose tissue—obesity	0.00186	0.0068	CbGeAlD
Glycine—SHMT2—cardiovascular system—obesity	0.00184	0.00671	CbGeAlD
Glycine—ALAS1—adrenal gland—obesity	0.00183	0.0067	CbGeAlD
Glycine—Urinary retention—Sibutramine—obesity	0.00182	0.00778	CcSEcCtD
Glycine—GCAT—endocrine gland—obesity	0.00181	0.00662	CbGeAlD
Glycine—Tachycardia—Diethylpropion—obesity	0.00181	0.00772	CcSEcCtD
Glycine—GLDC—liver—obesity	0.0018	0.00659	CbGeAlD
Glycine—Diarrhoea—Phendimetrazine—obesity	0.00178	0.00761	CcSEcCtD
Glycine—Dehydration—Sibutramine—obesity	0.00178	0.0076	CcSEcCtD
Glycine—GATM—adipose tissue—obesity	0.00177	0.00645	CbGeAlD
Glycine—Visual disturbance—Bupropion—obesity	0.00176	0.00752	CcSEcCtD
Glycine—Thirst—Bupropion—obesity	0.00175	0.00749	CcSEcCtD
Glycine—GARS—digestive system—obesity	0.00175	0.0064	CbGeAlD
Glycine—GSS—islet of Langerhans—obesity	0.00173	0.00634	CbGeAlD
Glycine—Dizziness—Phendimetrazine—obesity	0.00172	0.00735	CcSEcCtD
Glycine—Tachycardia—Cimetidine—obesity	0.00172	0.00734	CcSEcCtD
Glycine—GLRB—cardiovascular system—obesity	0.00172	0.00628	CbGeAlD
Glycine—Nausea—Benzphetamine—obesity	0.0017	0.00724	CcSEcCtD
Glycine—Urticaria—Phentermine—obesity	0.00169	0.00722	CcSEcCtD
Glycine—PIPOX—liver—obesity	0.00168	0.00616	CbGeAlD
Glycine—GARS—adrenal gland—obesity	0.00167	0.0061	CbGeAlD
Glycine—Cardiovascular disorder—Topiramate—obesity	0.00167	0.00712	CcSEcCtD
Glycine—GATM—digestive system—obesity	0.00166	0.00608	CbGeAlD
Glycine—Hypersensitivity—Phenylpropanolamine—obesity	0.00164	0.007	CcSEcCtD
Glycine—GSS—respiratory system—obesity	0.00164	0.00599	CbGeAlD
Glycine—GCAT—liver—obesity	0.00163	0.00597	CbGeAlD
Glycine—SHMT2—pituitary gland—obesity	0.00162	0.00594	CbGeAlD
Glycine—L-Cysteine—GOT1—obesity	0.00162	0.132	CrCbGaD
Glycine—SHMT2—adipose tissue—obesity	0.00162	0.00591	CbGeAlD
Glycine—Angina pectoris—Sibutramine—obesity	0.00161	0.00688	CcSEcCtD
Glycine—ALAS1—endocrine gland—obesity	0.00159	0.00581	CbGeAlD
Glycine—Urinary retention—Bupropion—obesity	0.00159	0.00678	CcSEcCtD
Glycine—GATM—adrenal gland—obesity	0.00158	0.00579	CbGeAlD
Glycine—Dehydration—Bupropion—obesity	0.00155	0.00663	CcSEcCtD
Glycine—Nausea—Phendimetrazine—obesity	0.00155	0.0066	CcSEcCtD
Glycine—SHMT2—digestive system—obesity	0.00152	0.00557	CbGeAlD
Glycine—GLRB—pituitary gland—obesity	0.00152	0.00556	CbGeAlD
Glycine—GLRB—adipose tissue—obesity	0.00152	0.00554	CbGeAlD
Glycine—SHMT1—adipose tissue—obesity	0.00147	0.00538	CbGeAlD
Glycine—Urticaria—Diethylpropion—obesity	0.00147	0.00628	CcSEcCtD
Glycine—Dizziness—Phenylpropanolamine—obesity	0.00147	0.00628	CcSEcCtD
Glycine—Diarrhoea—Phentermine—obesity	0.00146	0.00622	CcSEcCtD
Glycine—SHMT2—adrenal gland—obesity	0.00145	0.0053	CbGeAlD
Glycine—GARS—endocrine gland—obesity	0.00145	0.00529	CbGeAlD
Glycine—ALAS1—liver—obesity	0.00143	0.00523	CbGeAlD
Glycine—Salivary hypersecretion—Topiramate—obesity	0.00142	0.00608	CcSEcCtD
Glycine—Vomiting—Phenylpropanolamine—obesity	0.00141	0.00604	CcSEcCtD
Glycine—Dizziness—Phentermine—obesity	0.00141	0.00601	CcSEcCtD
Glycine—SHMT1—digestive system—obesity	0.00139	0.00507	CbGeAlD
Glycine—GSS—adrenal cortex—obesity	0.00137	0.00502	CbGeAlD
Glycine—GATM—endocrine gland—obesity	0.00137	0.00502	CbGeAlD
Glycine—GLRB—adrenal gland—obesity	0.00136	0.00497	CbGeAlD
Glycine—Vomiting—Phentermine—obesity	0.00135	0.00578	CcSEcCtD
Glycine—Rhinitis—Sibutramine—obesity	0.00133	0.00567	CcSEcCtD
Glycine—Nausea—Phenylpropanolamine—obesity	0.00132	0.00564	CcSEcCtD
Glycine—SHMT1—adrenal gland—obesity	0.00132	0.00483	CbGeAlD
Glycine—GARS—liver—obesity	0.0013	0.00477	CbGeAlD
Glycine—Hypersensitivity—Cimetidine—obesity	0.0013	0.00554	CcSEcCtD
Glycine—Visual impairment—Sibutramine—obesity	0.00128	0.00545	CcSEcCtD
Glycine—Diarrhoea—Diethylpropion—obesity	0.00127	0.00541	CcSEcCtD
Glycine—Nausea—Phentermine—obesity	0.00126	0.0054	CcSEcCtD
Glycine—SHMT2—endocrine gland—obesity	0.00126	0.0046	CbGeAlD
Glycine—SLC36A1—adipose tissue—obesity	0.00126	0.00459	CbGeAlD
Glycine—GSS—cardiovascular system—obesity	0.00125	0.00458	CbGeAlD
Glycine—GATM—liver—obesity	0.00124	0.00453	CbGeAlD
Glycine—Dizziness—Diethylpropion—obesity	0.00122	0.00523	CcSEcCtD
Glycine—Polyuria—Topiramate—obesity	0.00121	0.00517	CcSEcCtD
Glycine—Diarrhoea—Cimetidine—obesity	0.00121	0.00515	CcSEcCtD
Glycine—Chills—Sibutramine—obesity	0.00119	0.00508	CcSEcCtD
Glycine—SLC36A1—digestive system—obesity	0.00118	0.00432	CbGeAlD
Glycine—Vomiting—Diethylpropion—obesity	0.00118	0.00503	CcSEcCtD
Glycine—Dizziness—Cimetidine—obesity	0.00117	0.00497	CcSEcCtD
Glycine—Rhinitis—Bupropion—obesity	0.00116	0.00494	CcSEcCtD
Glycine—Back pain—Orlistat—obesity	0.00115	0.00492	CcSEcCtD
Glycine—SHMT1—endocrine gland—obesity	0.00115	0.00419	CbGeAlD
Glycine—SHMT2—liver—obesity	0.00113	0.00415	CbGeAlD
Glycine—GRIN2A—adrenal gland—obesity	0.00113	0.00414	CbGeAlD
Glycine—SLC36A1—adrenal gland—obesity	0.00113	0.00412	CbGeAlD
Glycine—Vision blurred—Orlistat—obesity	0.00112	0.0048	CcSEcCtD
Glycine—Visual disturbance—Topiramate—obesity	0.00112	0.00479	CcSEcCtD
Glycine—Vomiting—Cimetidine—obesity	0.00112	0.00478	CcSEcCtD
Glycine—Thirst—Topiramate—obesity	0.00112	0.00477	CcSEcCtD
Glycine—Back pain—Sibutramine—obesity	0.00112	0.00476	CcSEcCtD
Glycine—Visual impairment—Bupropion—obesity	0.00111	0.00475	CcSEcCtD
Glycine—GSS—pituitary gland—obesity	0.00111	0.00406	CbGeAlD
Glycine—GSS—adipose tissue—obesity	0.00111	0.00404	CbGeAlD
Glycine—Nausea—Diethylpropion—obesity	0.0011	0.0047	CcSEcCtD
Glycine—Vision blurred—Sibutramine—obesity	0.00109	0.00464	CcSEcCtD
Glycine—Vertigo—Orlistat—obesity	0.00107	0.00457	CcSEcCtD
Glycine—Hyponatraemia—Topiramate—obesity	0.00107	0.00456	CcSEcCtD
Glycine—Nausea—Cimetidine—obesity	0.00105	0.00447	CcSEcCtD
Glycine—GSS—digestive system—obesity	0.00104	0.00381	CbGeAlD
Glycine—Chills—Bupropion—obesity	0.00104	0.00442	CcSEcCtD
Glycine—Vertigo—Sibutramine—obesity	0.00104	0.00442	CcSEcCtD
Glycine—SHMT1—liver—obesity	0.00103	0.00378	CbGeAlD
Glycine—Convulsion—Orlistat—obesity	0.00103	0.00441	CcSEcCtD
Glycine—Urinary retention—Topiramate—obesity	0.00101	0.00432	CcSEcCtD
Glycine—Convulsion—Sibutramine—obesity	0.001	0.00427	CcSEcCtD
Glycine—GSS—adrenal gland—obesity	0.000992	0.00363	CbGeAlD
Glycine—Dehydration—Topiramate—obesity	0.00099	0.00422	CcSEcCtD
Glycine—GRIN2A—endocrine gland—obesity	0.000984	0.00359	CbGeAlD
Glycine—SLC36A1—endocrine gland—obesity	0.000977	0.00357	CbGeAlD
Glycine—Oedema—Orlistat—obesity	0.000973	0.00415	CcSEcCtD
Glycine—Back pain—Bupropion—obesity	0.000973	0.00415	CcSEcCtD
Glycine—Vision blurred—Bupropion—obesity	0.000948	0.00405	CcSEcCtD
Glycine—Oedema—Sibutramine—obesity	0.000942	0.00402	CcSEcCtD
Glycine—Tachycardia—Sibutramine—obesity	0.000919	0.00392	CcSEcCtD
Glycine—Vertigo—Bupropion—obesity	0.000904	0.00386	CcSEcCtD
Glycine—Angina pectoris—Topiramate—obesity	0.000896	0.00382	CcSEcCtD
Glycine—SLC36A1—liver—obesity	0.000881	0.00322	CbGeAlD
Glycine—Hypotension—Sibutramine—obesity	0.00088	0.00376	CcSEcCtD
Glycine—Convulsion—Bupropion—obesity	0.000871	0.00372	CcSEcCtD
Glycine—GSS—endocrine gland—obesity	0.00086	0.00314	CbGeAlD
Glycine—Pain—Orlistat—obesity	0.000832	0.00355	CcSEcCtD
Glycine—Oedema—Bupropion—obesity	0.000821	0.0035	CcSEcCtD
Glycine—SLC16A10—adipose tissue—obesity	0.00081	0.00296	CbGeAlD
Glycine—Pain—Sibutramine—obesity	0.000805	0.00344	CcSEcCtD
Glycine—Tachycardia—Bupropion—obesity	0.000801	0.00342	CcSEcCtD
Glycine—GSS—liver—obesity	0.000776	0.00284	CbGeAlD
Glycine—Urticaria—Orlistat—obesity	0.000773	0.0033	CcSEcCtD
Glycine—Hypotension—Bupropion—obesity	0.000767	0.00327	CcSEcCtD
Glycine—Urticaria—Sibutramine—obesity	0.000748	0.00319	CcSEcCtD
Glycine—Rhinitis—Topiramate—obesity	0.000738	0.00315	CcSEcCtD
Glycine—Hypersensitivity—Orlistat—obesity	0.000717	0.00306	CcSEcCtD
Glycine—Visual impairment—Topiramate—obesity	0.000709	0.00303	CcSEcCtD
Glycine—Pain—Bupropion—obesity	0.000702	0.003	CcSEcCtD
Glycine—Hypersensitivity—Sibutramine—obesity	0.000694	0.00296	CcSEcCtD
Glycine—Diarrhoea—Orlistat—obesity	0.000666	0.00284	CcSEcCtD
Glycine—Chills—Topiramate—obesity	0.000661	0.00282	CcSEcCtD
Glycine—Urticaria—Bupropion—obesity	0.000652	0.00278	CcSEcCtD
Glycine—Diarrhoea—Sibutramine—obesity	0.000644	0.00275	CcSEcCtD
Glycine—Dizziness—Orlistat—obesity	0.000643	0.00275	CcSEcCtD
Glycine—SLC16A10—endocrine gland—obesity	0.00063	0.0023	CbGeAlD
Glycine—Dizziness—Sibutramine—obesity	0.000623	0.00266	CcSEcCtD
Glycine—Back pain—Topiramate—obesity	0.00062	0.00265	CcSEcCtD
Glycine—Vomiting—Orlistat—obesity	0.000619	0.00264	CcSEcCtD
Glycine—Hypersensitivity—Bupropion—obesity	0.000605	0.00258	CcSEcCtD
Glycine—Vision blurred—Topiramate—obesity	0.000604	0.00258	CcSEcCtD
Glycine—Vomiting—Sibutramine—obesity	0.000599	0.00256	CcSEcCtD
Glycine—Nausea—Orlistat—obesity	0.000578	0.00247	CcSEcCtD
Glycine—Vertigo—Topiramate—obesity	0.000576	0.00246	CcSEcCtD
Glycine—SLC16A10—liver—obesity	0.000568	0.00208	CbGeAlD
Glycine—Diarrhoea—Bupropion—obesity	0.000562	0.0024	CcSEcCtD
Glycine—Nausea—Sibutramine—obesity	0.000559	0.00239	CcSEcCtD
Glycine—Convulsion—Topiramate—obesity	0.000555	0.00237	CcSEcCtD
Glycine—Dizziness—Bupropion—obesity	0.000543	0.00232	CcSEcCtD
Glycine—Oedema—Topiramate—obesity	0.000523	0.00223	CcSEcCtD
Glycine—Vomiting—Bupropion—obesity	0.000522	0.00223	CcSEcCtD
Glycine—Tachycardia—Topiramate—obesity	0.00051	0.00218	CcSEcCtD
Glycine—Hypotension—Topiramate—obesity	0.000489	0.00209	CcSEcCtD
Glycine—Nausea—Bupropion—obesity	0.000488	0.00208	CcSEcCtD
Glycine—Pain—Topiramate—obesity	0.000447	0.00191	CcSEcCtD
Glycine—Urticaria—Topiramate—obesity	0.000415	0.00177	CcSEcCtD
Glycine—Hypersensitivity—Topiramate—obesity	0.000385	0.00164	CcSEcCtD
Glycine—Diarrhoea—Topiramate—obesity	0.000358	0.00153	CcSEcCtD
Glycine—Dizziness—Topiramate—obesity	0.000346	0.00148	CcSEcCtD
Glycine—Vomiting—Topiramate—obesity	0.000333	0.00142	CcSEcCtD
Glycine—Nausea—Topiramate—obesity	0.000311	0.00133	CcSEcCtD
Glycine—GSS—Metabolism—GCG—obesity	2.39e-05	4.98e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—SLC2A4—obesity	2.39e-05	4.98e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PPARG—obesity	2.38e-05	4.97e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PPARG—obesity	2.38e-05	4.97e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PPARG—obesity	2.38e-05	4.97e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PPARG—obesity	2.38e-05	4.97e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARA—obesity	2.38e-05	4.95e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AGT—obesity	2.38e-05	4.95e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GGT1—obesity	2.38e-05	4.95e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GOT1—obesity	2.38e-05	4.95e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—LPL—obesity	2.36e-05	4.92e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYCS—obesity	2.36e-05	4.92e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CG—obesity	2.36e-05	4.91e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—POMC—obesity	2.35e-05	4.9e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—POMC—obesity	2.35e-05	4.9e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—POMC—obesity	2.35e-05	4.9e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—POMC—obesity	2.35e-05	4.9e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NCOA1—obesity	2.34e-05	4.88e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IRS2—obesity	2.34e-05	4.88e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—INS—obesity	2.34e-05	4.88e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—INS—obesity	2.34e-05	4.88e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—INS—obesity	2.34e-05	4.88e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—INS—obesity	2.34e-05	4.88e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AGT—obesity	2.34e-05	4.87e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOE—obesity	2.33e-05	4.85e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GGT1—obesity	2.32e-05	4.83e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GOT1—obesity	2.32e-05	4.83e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—MYC—obesity	2.31e-05	4.81e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—STK11—obesity	2.31e-05	4.81e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CYP19A1—obesity	2.31e-05	4.81e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—CAV1—obesity	2.31e-05	4.81e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—GPX1—obesity	2.3e-05	4.8e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—APOA1—obesity	2.3e-05	4.8e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AGT—obesity	2.3e-05	4.8e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—LPL—obesity	2.3e-05	4.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—LEP—obesity	2.29e-05	4.77e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOE—obesity	2.29e-05	4.77e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—FOXO1—obesity	2.28e-05	4.76e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NCOA1—obesity	2.28e-05	4.75e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PPARG—obesity	2.28e-05	4.74e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CAV1—obesity	2.27e-05	4.73e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—APOA1—obesity	2.26e-05	4.72e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOE—obesity	2.25e-05	4.7e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—STK11—obesity	2.25e-05	4.69e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CYP19A1—obesity	2.25e-05	4.69e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CD36—obesity	2.24e-05	4.68e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—POMC—obesity	2.24e-05	4.68e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CAV1—obesity	2.23e-05	4.66e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—INS—obesity	2.23e-05	4.65e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—APOA1—obesity	2.23e-05	4.65e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—ESR1—obesity	2.19e-05	4.56e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CD—obesity	2.17e-05	4.53e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CD—obesity	2.17e-05	4.53e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CD—obesity	2.17e-05	4.53e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CD—obesity	2.17e-05	4.53e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PRKCB—obesity	2.16e-05	4.5e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—F2—obesity	2.16e-05	4.5e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—ALB—obesity	2.14e-05	4.47e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—ALB—obesity	2.14e-05	4.47e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—COMT—obesity	2.14e-05	4.47e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—ALB—obesity	2.14e-05	4.47e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—ALB—obesity	2.14e-05	4.47e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.13e-05	4.45e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—BAD—obesity	2.13e-05	4.45e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MTHFR—obesity	2.13e-05	4.43e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PRKCD—obesity	2.12e-05	4.41e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNB3—obesity	2.11e-05	4.41e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARGC1A—obesity	2.11e-05	4.41e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—HMOX1—obesity	2.1e-05	4.39e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CG—obesity	2.1e-05	4.38e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—COMT—obesity	2.09e-05	4.36e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARA—obesity	2.09e-05	4.35e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CD—obesity	2.07e-05	4.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTHFR—obesity	2.07e-05	4.31e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CG—obesity	2.07e-05	4.31e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARGC1A—obesity	2.06e-05	4.29e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GNB3—obesity	2.06e-05	4.29e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GNAS—obesity	2.06e-05	4.29e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—PPARA—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3R1—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3R1—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—NOS3—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3R1—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3R1—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—NOS3—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—NOS3—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—HMOX1—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—NOS3—obesity	2.05e-05	4.28e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—ALB—obesity	2.05e-05	4.26e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IRS1—obesity	2.04e-05	4.26e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CG—obesity	2.03e-05	4.24e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PPARG—obesity	2.03e-05	4.23e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AGT—obesity	2.02e-05	4.21e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOB—obesity	2.02e-05	4.2e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GNAS—obesity	2.01e-05	4.18e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—POMC—obesity	2e-05	4.17e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—INS—obesity	1.99e-05	4.15e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOE—obesity	1.98e-05	4.13e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IRS2—obesity	1.97e-05	4.1e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—POMC—obesity	1.97e-05	4.1e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOB—obesity	1.96e-05	4.1e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PPARG—obesity	1.96e-05	4.09e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CAV1—obesity	1.96e-05	4.09e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—APOA1—obesity	1.96e-05	4.08e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—NOS3—obesity	1.96e-05	4.08e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3R1—obesity	1.96e-05	4.08e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—INS—obesity	1.96e-05	4.08e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—POMC—obesity	1.94e-05	4.04e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOE—obesity	1.93e-05	4.02e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—INS—obesity	1.93e-05	4.01e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—LPL—obesity	1.93e-05	4.01e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—APOA1—obesity	1.92e-05	4.01e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CCL2—obesity	1.92e-05	4.01e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—CAV1—obesity	1.91e-05	3.98e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—APOA1—obesity	1.9e-05	3.97e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CB—obesity	1.89e-05	3.95e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CB—obesity	1.89e-05	3.95e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CB—obesity	1.89e-05	3.95e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CB—obesity	1.89e-05	3.95e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IGF1—obesity	1.89e-05	3.94e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT2—obesity	1.89e-05	3.94e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—GPX1—obesity	1.88e-05	3.91e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—LPL—obesity	1.88e-05	3.91e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PTGS2—obesity	1.88e-05	3.91e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PTGS2—obesity	1.88e-05	3.91e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PTGS2—obesity	1.88e-05	3.91e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PTGS2—obesity	1.88e-05	3.91e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CD—obesity	1.85e-05	3.85e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—GPX1—obesity	1.83e-05	3.81e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CD36—obesity	1.83e-05	3.81e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—ALB—obesity	1.82e-05	3.8e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CD—obesity	1.82e-05	3.79e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CB—obesity	1.81e-05	3.76e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—PIK3CA—obesity	1.8e-05	3.75e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—SERPINE1—obesity	1.8e-05	3.74e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—BAD—obesity	1.8e-05	3.74e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PTGS2—obesity	1.79e-05	3.73e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CD—obesity	1.79e-05	3.73e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CG—obesity	1.79e-05	3.72e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CD36—obesity	1.78e-05	3.72e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—ALB—obesity	1.77e-05	3.68e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TYK2—obesity	1.75e-05	3.64e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3R1—obesity	1.74e-05	3.64e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—NOS3—obesity	1.74e-05	3.64e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MTHFR—obesity	1.73e-05	3.61e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—RHOA—obesity	1.73e-05	3.61e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PPARG—obesity	1.72e-05	3.59e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IRS1—obesity	1.72e-05	3.58e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3R1—obesity	1.72e-05	3.57e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—NOS3—obesity	1.72e-05	3.57e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—POMC—obesity	1.7e-05	3.54e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARA—obesity	1.7e-05	3.54e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—INS—obesity	1.69e-05	3.52e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—NOS3—obesity	1.69e-05	3.52e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—MTHFR—obesity	1.69e-05	3.52e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3R1—obesity	1.69e-05	3.52e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARA—obesity	1.66e-05	3.45e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AGT—obesity	1.65e-05	3.43e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—INS—obesity	1.65e-05	3.43e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—PIK3CA—obesity	1.63e-05	3.41e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOE—obesity	1.61e-05	3.36e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CB—obesity	1.61e-05	3.36e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AGT—obesity	1.61e-05	3.35e-05	CbGpPWpGaD
Glycine—GARS—Gene Expression—AKT1—obesity	1.6e-05	3.33e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CAV1—obesity	1.6e-05	3.33e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PTGS2—obesity	1.6e-05	3.32e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—APOA1—obesity	1.6e-05	3.32e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT2—obesity	1.59e-05	3.32e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MTOR—obesity	1.58e-05	3.3e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CB—obesity	1.58e-05	3.3e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOE—obesity	1.57e-05	3.28e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CD—obesity	1.57e-05	3.27e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CB—obesity	1.56e-05	3.25e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—CAV1—obesity	1.56e-05	3.25e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—APOA1—obesity	1.55e-05	3.24e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—ALB—obesity	1.55e-05	3.23e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PTGS2—obesity	1.55e-05	3.22e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CD—obesity	1.53e-05	3.19e-05	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—ALB—obesity	1.52e-05	3.18e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—PIK3CA—obesity	1.52e-05	3.17e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—SERPINE1—obesity	1.51e-05	3.15e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—NOS3—obesity	1.48e-05	3.09e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3R1—obesity	1.48e-05	3.09e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TYK2—obesity	1.47e-05	3.07e-05	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—AKT1—obesity	1.47e-05	3.06e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—RHOA—obesity	1.46e-05	3.04e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CG—obesity	1.46e-05	3.04e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—IL6—obesity	1.45e-05	3.02e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—NOS3—obesity	1.44e-05	3.01e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3R1—obesity	1.44e-05	3.01e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CG—obesity	1.42e-05	2.96e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PPARG—obesity	1.41e-05	2.93e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—POMC—obesity	1.39e-05	2.89e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—INS—obesity	1.38e-05	2.87e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MMP9—obesity	1.38e-05	2.87e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PPARG—obesity	1.37e-05	2.85e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CB—obesity	1.37e-05	2.85e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PTGS2—obesity	1.36e-05	2.83e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—POMC—obesity	1.35e-05	2.82e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—INS—obesity	1.34e-05	2.8e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MAPK8—obesity	1.34e-05	2.79e-05	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—AKT1—obesity	1.33e-05	2.78e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CB—obesity	1.33e-05	2.78e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MTOR—obesity	1.33e-05	2.78e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PTGS2—obesity	1.32e-05	2.75e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CD—obesity	1.28e-05	2.67e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—ALB—obesity	1.26e-05	2.63e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CD—obesity	1.25e-05	2.6e-05	CbGpPWpGaD
Glycine—ALAS2—Metabolism—AKT1—obesity	1.24e-05	2.59e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—ALB—obesity	1.23e-05	2.57e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—STAT3—obesity	1.22e-05	2.55e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—NOS3—obesity	1.21e-05	2.52e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3R1—obesity	1.21e-05	2.52e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3R1—obesity	1.18e-05	2.46e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—NOS3—obesity	1.18e-05	2.46e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—PIK3CA—obesity	1.15e-05	2.41e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—PIK3CA—obesity	1.15e-05	2.41e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—PIK3CA—obesity	1.15e-05	2.41e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—PIK3CA—obesity	1.15e-05	2.41e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—MYC—obesity	1.14e-05	2.37e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—TGFB1—obesity	1.13e-05	2.36e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CB—obesity	1.12e-05	2.33e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PTGS2—obesity	1.11e-05	2.3e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—PIK3CA—obesity	1.1e-05	2.29e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CB—obesity	1.09e-05	2.27e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PTGS2—obesity	1.08e-05	2.25e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—STAT3—obesity	1.03e-05	2.15e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—PIK3CA—obesity	9.81e-06	2.05e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—PIK3CA—obesity	9.65e-06	2.01e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—MYC—obesity	9.57e-06	1.99e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—TGFB1—obesity	9.55e-06	1.99e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—PIK3CA—obesity	9.51e-06	1.98e-05	CbGpPWpGaD
Glycine—GATM—Metabolism—AKT1—obesity	9.43e-06	1.97e-05	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—AKT1—obesity	9.43e-06	1.97e-05	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—AKT1—obesity	9.43e-06	1.97e-05	CbGpPWpGaD
Glycine—GLYAT—Metabolism—AKT1—obesity	9.43e-06	1.97e-05	CbGpPWpGaD
Glycine—BAAT—Metabolism—AKT1—obesity	9e-06	1.87e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—IL6—obesity	8.55e-06	1.78e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—PIK3CA—obesity	8.35e-06	1.74e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—PIK3CA—obesity	8.12e-06	1.69e-05	CbGpPWpGaD
Glycine—AGXT—Metabolism—AKT1—obesity	8.02e-06	1.67e-05	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—AKT1—obesity	7.88e-06	1.64e-05	CbGpPWpGaD
Glycine—ALAS1—Metabolism—AKT1—obesity	7.77e-06	1.62e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—IL6—obesity	7.19e-06	1.5e-05	CbGpPWpGaD
Glycine—AGXT2—Metabolism—AKT1—obesity	6.82e-06	1.42e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—PIK3CA—obesity	6.8e-06	1.42e-05	CbGpPWpGaD
Glycine—SHMT1—Disease—AKT1—obesity	6.64e-06	1.38e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—PIK3CA—obesity	6.63e-06	1.38e-05	CbGpPWpGaD
Glycine—SHMT1—Metabolism—AKT1—obesity	5.56e-06	1.16e-05	CbGpPWpGaD
Glycine—GSS—Metabolism—AKT1—obesity	5.42e-06	1.13e-05	CbGpPWpGaD
